I strongly urge Ms. Mills to revisit this decision and allow small businesses that have majority investment by venture capital firms to be eligible to compete again in the SBIR program.
Editor's note · Context
Landrieu calls for reconsideration of the decision affecting small biotech companies' participation in the SBIR program.
Share
More from Mary Landrieu
I wish to call attention to the bill itself. We talk about many bills, but we don't really debate many bills, so this has been a refreshing day on the floor of the Senate. I have not really seen a day like this in 8 years. I am encouraged…
I thank the Presiding Officer. First of all, let me associate myself with the remarks of my cosponsor, Senator Hoeven, who before he had to slip out the door to take a call relative to this vote was really very clear on so many important…
I want to thank the Senator from Delaware for raising these important issues. I agree with his understanding and description of the land acquisition provisions for the First State National Historical Park within H.R. 3979, that the…





